Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 3/20 | 0.47 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.47 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.47 |
| ▸ | MLNR known ✓ | O43193 | 1/20 | 0.47 |
| ▸ | EGFR known ✓ | P00533 | 1/20 | 0.47 |
| ▸ | ERBB2 known ✓ | P04626 | 1/20 | 0.47 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.47 |
| ▸ | ADRB1 known ✓ | P08588 | 1/20 | 0.47 |
| ▸ | HTR1A known ✓ | P08908 | 1/20 | 0.47 |
| ▸ | ADRA2A known ✓ | P08913 | 1/20 | 0.47 |
| ▸ | DRD2 known ✓ | P14416 | 1/20 | 0.47 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.47 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.47 |
| ▸ | DRD1 known ✓ | P21728 | 1/20 | 0.47 |
| ▸ | ADRA1D known ✓ | P25100 | 1/20 | 0.47 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.47 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.47 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.47 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.47 |
| ▸ | ADRA1B known ✓ | P35368 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL9563255 | 1.00 | BCHE (0.51) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563263 | 0.94 | BCHE (0.52) | BCHECHRM3HRH1LMNASLC6A2 | |
| Hydrochloric Acid SCHEMBL9563254 | 0.93 | BCHE (0.51) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563179 | 0.91 | BCHE (0.56) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563339 | 0.90 | BCHE (0.55) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563184 | 0.89 | BCHE (0.48) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563225 | 0.89 | HTR1A (0.48) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563309 | 0.89 | BCHE (0.55) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9563384 | 0.89 | PARP14 (0.49) | BCHECHRM3HRH1LMNASLC6A2 | |
| SCHEMBL9600620 | 0.88 | BCHE (0.46) | BCHECHRM3HRH1LMNASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0529365-A1 | Diarylmethoxypiperidine derivatives | Kaken Pharmaceutical Co., Ltd. (JP) | 1993-03-03 | — | — | EP | disclosed |
| US-5190959-A | Antihistamines, antiallergens, treatment of ischemic heart disease | KAKEN PHARMACEUTICAL CO. LTD. (JP) | 1993-03-02 | — | — | US | disclosed |